4967 On Other Exchanges
Symbol
Exchange
4967 is not on other exchanges.

Executive Profile*

Yutaka Kobayashi

AgeTotal Calculated CompensationThis person is connected to 20 board members in 2 different organizations across 4 different industries.

See Board Relationships
----
As of Fiscal Year 2016

Background*

Mr. Yutaka Kobayashi serves as the Chief Executive Officer and President of Kureha America, Inc., and Kureha Corporation. Mr. Kobayashi has been the President of Kobayashi Pharmaceutical Co Ltd. since June 2004 and also serves as its Chief Operating Officer. Mr. Kobayashi served as a Senior Executive Vice President of Kureha Corporation (alternate name Kureha Chemical Industry Co. Ltd). He served as a Vice President at Kureha Corporation. Mr. Kobayashi served as Senior ...

Read Full Background

Corporate Headquarters*

KDX Kobayashi Doshomachi Building
Osaka, -- 541-0045

Japan

Phone: 81 6 6222 0142
Fax: 81 6 6222 4261

Board Members Memberships*

Chief Executive Officer, President, Director, Chairman of Compliance Committee and Chairman of Executive Committee
Vice Chairman

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
David R. Hummel BScChief Executive Officer and Executive Director
Victrex plc
521.9K GBP
Inge G. Thulin Chairman, Chief Executive Officer and President
3M Company
$1.4M
Jean-Pierre Clamadieu Chief Executive Officer, Director and Member of Finance Committee
Solvay SA
--
Feike Sijbesma Chairman of the Managing Board and Chief Executive Officer
Koninklijke DSM N.V.
€1.4M
Thierry Le Hénaff Chairman of the Board, Chief Executive Officer, Chairman of Arkema France and Director of Arkema France
Arkema S.A.
€1.9M
Compensation as of Fiscal Year 2016.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact KOBAYASHI PHARMACEUTICAL CO, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.